The search textbox has an autosuggest feature. When you enter three or more characters,
a list of up to 10 suggestions will popup under the textbox. Use the arrow keys
to move through the suggestions. To select a suggestion, hit the enter key. Using
the escape key closes the listbox and puts you back at the textbox. The radio buttons
allow you to toggle between having all search items start with or contain the text
you entered in the search box.
mitoguazone
A guanylhydrazone with potential antineoplastic activity. Mitoguazone competitively inhibits S-adenosyl-L-methionine decarboxylase (SAMD), an enzyme involved in the synthesis of polyamines, resulting in decreased proliferation of tumor cells, antimitochondrial effects, and p53-independent apoptosis. Polyamines, specifically spermine and spermidine, are essential for thymidine kinase production, DNA synthesis, and cell proliferation. Check for active clinical trials or closed clinical trials using this agent. (NCI Thesaurus)
| Synonyms: | | methylglyoxal bisguanylhydrazone mitoguazone dihydrochloride pyruvaldehyde bis(amidinohydrazone) | |
| |||
| Foreign brand name: | | Zyrkamine | |
| |||
| Abbreviations: | | MeGAG methyl-G methyl-GAG MGBG MGGH | |
| |||
| Code names: | | DRG-0223 NSC 32946 | |
| |||
| Chemical structures: | | 1,1'-[(methylethanediylidene)dinitrilo)diguanidine 2,2"-(methyl-1,2-ethanediylidene)bis[hydrazinecarboximidamide] methylglyoxal bis(amidinohydrazone) | |
| |||
